Telomere and Telomerase
NCT01176422 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2017-01-10
Summary
Researchers hope to determine if the DNA is shortened in your body and determine if there is an increase in the protein that shortens DNA called telomerase.
Conditions
Interventions
- GENETIC
-
Blood sample
Blood samples will be collected before and after treatment completion.
Sponsors & Collaborators
-
University of Kansas Medical Center
lead OTHER
Principal Investigators
-
Siddhartha Ganguly, MD · University of Kansas Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2011-02-28
- Completion
- 2011-02-28
Countries
- United States
Study Locations
More Related Trials
-
Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia
NCT01016379 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma
NCT01510600 ·Status: COMPLETED
-
Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia
NCT01146223 ·Status: COMPLETED
-
Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882
NCT00898469 ·Status: COMPLETED
-
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
NCT00898664 ·Status: COMPLETED
-
DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia
NCT00899366 ·Status: COMPLETED
-
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics
NCT03027401 ·Status: WITHDRAWN
-
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia
NCT01139333 ·Status: COMPLETED
-
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
NCT01434329 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
NCT01433224 ·Status: COMPLETED
-
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
NCT01653613 ·Status: UNKNOWN
-
The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia
NCT01010256 ·Status: TERMINATED
-
A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing
NCT02705404 ·Status: TERMINATED
-
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
NCT00899002 ·Status: WITHDRAWN
-
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
NCT00900289 ·Status: UNKNOWN
-
Association Between Mitochondrial DNA Content and Risk of Acute Leukemia
NCT03595969 ·Status: COMPLETED
-
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"
NCT03071809 ·Status: TERMINATED
-
MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies
NCT06543511 ·Status: WITHDRAWN ·Phase: NA
-
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
NCT05676450 ·Status: RECRUITING ·Phase: NA
-
Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia
NCT01057095 ·Status: COMPLETED
-
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia
NCT01119586 ·Status: COMPLETED
-
Sample Collection From Melanoma Patients
NCT00507325 ·Status: TERMINATED
-
Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation
NCT02412579 ·Status: COMPLETED
-
Germline Testing for Predisposition to Myeloid Malignancies
NCT07112287 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723 ·Status: RECRUITING